ArticleTobacco induced diseases2023
Effectiveness and determinants of smoking cessation in the Saudi Arabian Region of Jazan: A cross-sectional study.
Article in Tobacco induced diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 6 citations in OpenAlex.
- Early Initiation and Dual Patterns of Cigarette and E-Cigarette Use among Adults in the Eastern Province, Saudi Arabia:Saudi medical journal · 2026Article
- Article
- Quit attempts and cessation support among youth smokers in Saudi Arabia: A cross-sectional analysis of the 2022 Global Youth Tobacco Survey.Tobacco induced diseases · 2026Article
- Awareness and perceptions of nicotine replacement therapy among adults in Saudi Arabia: A cross-sectional study.Tobacco induced diseases · 2026Article
- Effectiveness of family-based behavioral intervention for smoking cessation in low-income households: a systematic review and meta-analysis.EClinicalMedicine · 2025Article
- Smoking Abstinence Self-Efficacy, Decisional Balance, and Quitting Desire Among Adult Smokers in Saudi Arabia: Gender-Based Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2025Article
- Predicting Smoking Cessation Stages: An Insight from the Transtheoretical Model Using a Cross-Sectional Approach Among Adults in Saudi Arabia.Healthcare (Basel, Switzerland) · 2024Article
- Probability and predictors of long-term smoking relapse among Chinese adult smokers: A longitudinal study.Preventive medicine reports · 2023Article
Corrections and comments
- Erratum issued
Authors and funding
15 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSmoking cessation has significant health benefits. The purpose of this study is to assess the efficacy and related factors of smoking cessation therapies in the Jazan Region of Saudi Arabia.
methodsThis is a cross-sectional study that took place at smoking cessation clinics in primary healthcare centers between January 2019 and January 2020.
resultsThis study enrolled a total of 103 people. The success rate for quitting smoking was 36% at three months, with a 13% relapse rate at six months. Age (p=0.017), occupation (p=0.046), daily cigarette intake (p=0.015), and number of visits (p=0.001) were all found to be significant determinants of smoking cessation. In the multivariate analysis, only the number of visits increased the likelihood to quit smoking (AOR=0.31; 95% CI: 0.15-0.63). Self-efficacy was cited as the primary reason for quitting smoking by 71% of the participants, whereas family support, smoking cessation therapies, and friends' support were cited as predictive variables by 18%, 10%, and 1% of the participants, respectively.
conclusionsSmokers who received the smoking cessation intervention package were three times more likely to succeed in giving up smoking when compared to those who received the routine service. Regular follow-up during smoking cessation interventions significantly enhanced the quit rate. It is recommended that pharmacotherapy strategies and intense therapy performed face-to-face with a cessation counselor be combined to improve the quit rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.